I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
Multicenter, Retrospective Study to Evaluate Necitumumab Pl..:
Yasunori Murata, MD, PhD
;
Shigeru Tanzawa, MD, PhD
;
Toshihiro Misumi, PhD
...
http://www.sciencedirect.com/science/article/pii/S2666364323001364. , 2023
Link:
https://doi.org/10.1016/j.jtocrr.2023.100593
RT Journal T1
Multicenter, Retrospective Study to Evaluate Necitumumab Plus Cisplatin and Gemcitabine After Immune Checkpoint Inhibitors in Advanced Squamous Cell Lung Cancer in Japan: The NINJA Study
UL https://suche.suub.uni-bremen.de/peid=base-ftdoajarticles:oai:doaj.org_article:0e1d4e104d1e4f01bd75edf40b9e925c&Exemplar=1&LAN=DE A1 Yasunori Murata, MD, PhD A1 Shigeru Tanzawa, MD, PhD A1 Toshihiro Misumi, PhD A1 Hiroshige Yoshioka, MD, PhD A1 Eisaku Miyauchi, MD, PhD A1 Kiichiro Ninomiya, MD, PhD A1 Masafumi Takeshita, MD, PhD A1 Kensaku Ito, MD, PhD A1 Tatsuro Okamoto, MD, PhD A1 Shunichi Sugawara, MD, PhD A1 Yosuke Kawashima, MD A1 Kazuki Hashimoto, MD A1 Masahide Mori, MD, PhD A1 Akihiko Miyanaga, MD, PhD A1 Anna Hayashi, MD A1 Hisashi Tanaka, MD, PhD A1 Ryoichi Honda, MD, PhD A1 Masafumi Nojiri, MD, PhD A1 Yuki Sato, MD A1 Akito Hata, MD A1 Ken Masuda, MD, PhD A1 Toshiyuki Kozuki, MD, PhD A1 Takahisa Kawamura, MD, PhD A1 Takuji Suzuki, MD, PhD A1 Teppei Yamaguchi, MD, PhD A1 Kazuhiro Asada, MD, PhD A1 Satoshi Tetsumoto, MD, PhD A1 Hiroshi Tanaka, MD, PhD A1 Satoshi Watanabe, MD, PhD A1 Yukihiro Umeda, MD, PhD A1 Kakuhiro Yamaguchi, MD, PhD A1 Shoichi Kuyama, MD, PhD A1 Kosuke Tsuruno, MD, PhD A1 Yuki Misumi, MD, PhD A1 Hiroshi Kuraishi, MD, PhD A1 Ken Yoshihara, MD, PhD A1 Akira Nakao, MD, PhD A1 Akihito Kubo, MD, PhD A1 Toshihiko Yokoyama, MD, PhD A1 Kana Watanabe, MD, PhD A1 Nobuhiko Seki, MD, PhD PB Elsevier YR 2023 K1 Necitumumab K1 Immune checkpoint inhibitor K1 Platinum rechallenge K1 Skin disorder K1 Lung squamous cell carcinoma K1 Neoplasms. Tumors. Oncology. Including cancer and carcinogens K1 RC254-282 JF http://www.sciencedirect.com/science/article/pii/S2666364323001364 LK http://dx.doi.org/https://doi.org/10.1016/j.jtocrr.2023.100593 DO https://doi.org/10.1016/j.jtocrr.2023.100593 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)